PerpEquities

Equity · Healthcare

Illumina, Inc. (ILMN) perpetual futures

ILMN perpetual futures on 1 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade ILMNUSDT.

Illumina provides sequencing and array technologies and related instruments, consumables and genotyping services for research, clinical and diagnostic customers worldwide.

$207.64-8.2%NASDAQ closed
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

Collecting venue price data...
venue perp mark · MEXC (ILMN/USDT)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

1/2 live markets
Venues
2
Live markets
1/2
24h volume
$193K
Open interest
$108.4K
Best liquidity
$29.3K
MEXC
Tightest spread
+81.6 bps
MEXC
Highest volume
$193K
MEXC
Settlement mix
USDT · 2/2
Perp/spot vol.
0.00x
Spot volume $878.8M
OI / float
0.00%
Float $31.3B
Spot performance
1D-8.18%
5D-18.68%
1M-23.96%
6M+45.88%
YTD+58.58%
1Y+71.74%

Venue matrix

2 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
MEXCTradeILMN/USDTTrading$207.64+21.9% APR
+0.020% every 8h
+81.6 bps$29.3K$193K$108.4KUSDT20x
BingXTradeILMN-USDTWatchlist------USDT-

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

No sufficient depth · 0 of 1 venues absorb $10k

Too thin: MEXC

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

ILMN

Tightest spread

ILMN

Highest volume

ILMN

Funding history

Stored venue snapshots by market

Company financials

Financials at a glance

Last report Q3 '26 · filed 2026-10-30 · next report 2027-02-04 · Updated 109h ago
All financials →

Valuation & key figures

Market cap
$35.6B
Updated 109h ago
Revenue
$4.5B
Trailing 12 months
Revenue growth
+7%
Next fiscal year
Profit margin
+19.7%
P/E
40.1
Peer P/E 25.5
P/S
7.9
Peer P/E
25.5
Similar listed perps
Free cash flow
$1.1B
Trailing 12 months
Net income
$895M
Trailing 12 months
Revenue estimate
$4.6B
Next fiscal year
Earnings
2027-02-04
Revenue est. $1.2B · Updated 109h ago
Dividend
-
Revenue (TTM)$4.54B+5.9% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)22.4%+2.8 pp vs a year agoOperating income $1.02B
Net income (TTM)$895M+27.3% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)$1.06B+5.0% vs a year agoCapex $173M
Diluted EPS (TTM)$5.82+30.5% vs a year agoSum of the last 4 quarters
Net cash-$976M+24.8% vs a year agoCash + short-term investments - debt
  • Revenue growth steady: 4.2% year on yearQ3 '26 revenue $1.13B, against an average of 5.0% over the four quarters before.
  • Operating margin 22.4% (TTM), +2.8 pp on a year agoOperating income grew 21.1% while revenue grew 5.9%.
  • Capex 3.8% of revenue (a year ago 2.7%)$173M invested in the last 4 quarters (+50.4% on a year earlier). Free cash flow $1.06B = 118.1% of net income.
  • Returned $51M to shareholders = 4.8% of free cash flowBuybacks $51M (a year earlier $717M), dividends $0, stock-based pay $0 (TTM).

Revenue, operating income and growth

quarterly

Revenue by business line

latest quarter
LineRevenuey/yShare
Sequencing$1.02B+2.0%90.4%
Microarray$108M+30.1%9.6%
In the full financialsIncome statement, balance sheet and cash flow (12 quarters / 10 years) · margins and cost structure · capital allocation and buybacks · valuation against the 5-year range · analyst estimates · all 250 lines Illumina, Inc. reported to the SEC

Next catalyst

Catalysts

Earnings
2027-02-04
Revenue est. $1.2B · Updated 109h ago

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20265.40$4.6B+7%11
FY 20276.14$4.9B+14%12
FY 20287.03$5.3B+22%7
FY 20298.03$5.8B+33%4
FY 20308.95$6.1B+42%2
Q1 20271.33$1.2B+6%7

Company events

6
2027-02-04EarningsActual - / Estimate 1.51-
2026-10-29Earnings · After market closeActual 1.62 / Estimate 1.36Beat
2026-07-30EarningsActual 1.31 / Estimate 1.23Beat
2026-04-30EarningsActual 1.15 / Estimate 1.05Beat
2026-02-05EarningsActual 1.35 / Estimate 1.24Beat
2025-10-30EarningsActual 1.34 / Estimate 1.17Beat

Peer comparison

Similar listed perps

Company data

Company intelligence

Updated: Nov 2, 2026, 05:15 PM UTC

Company profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Chief executive
Jacob Thaysen
Employees
8,600
IPO date
Jul 28, 2000
Country
US
Exchange
NASDAQ Global Select
Website
Altman Z-scorei7.4
Piotroski scorei7/9
Overall ratingiB
Owner earningsi$394.20M$2.56 per share
ESG risk ratingiBIndustry rank: 15 out of 62

Rating factors

Return on equityi
5
Return on assetsi
5
Debt to equityi
1
Price to earningsi
1
Price to booki
1
Market cap history
$34.20B+14.3%Aug 26 – Nov 26
$28.96B$36.65B$44.35BHigh: $44.35B · 2026-10-05Low: $28.96B · 2026-08-10Latest: $34.20B · 2026-11-02Aug 26Sep 26Oct 26Nov 26
Latest: $34.20B · 2026-11-02High: $44.35B · 2026-10-05Low: $28.96B · 2026-08-10
Largest fund holders
FundWeightShares held
BSCP0.3%6.9M
NJH0.63%5.2M
VTI0.06%4.8M
VOO0.06%4M
VB0.52%3.4M
FXAIX0.06%2.3M
FOCKX1.05%2.1M
IVV0.05%2M
1657.T0.04%2M
XSP.TO0.06%2M
VBK1.18%1.9M
SPY0.07%1.8M

Analyst track record

How the analysts covering ILMN have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings113420
Analysts2432
Buy / hold / sell49 / 39 / 25191 / 154 / 75
Upgrades / downgrades / initiations4 / 2 / 212 / 13 / 5
Price targets hit / missed88 / 23 (79%)352 / 45 (89%)
Avg. return after a rating (TipRanks)+39.4%+67.1%
Best / worst call+459.5% / -29.2%+459.5% / -29.2%

After buy calls on this stock: median 21-day move +2.8% vs S&P 500 0.0% (n = 196)

Most accurate on this stock

Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.

  1. Michael RyskinBank of America Securities78% hit rate on this stock · 27 targets measuredSelltarget $168Oct 9, 2026
  2. Puneet SoudaLeerink Partners68% hit rate on this stock · 19 targets measuredBuytarget $300Sep 29, 2026
  3. Luke SergottBarclays50% hit rate on this stock · 18 targets measuredSelltarget $200Oct 30, 2026

Latest ratings

DateAnalystCallTarget
Nov 5, 2026Catherine Ramsey SchulteRobert W. BairdHoldMaintained$236
Nov 2, 2026Ilya ZubkovFreedom Capital MarketsHoldMaintained$200
Nov 2, 2026Patrick B DonnellyCitiSellMaintained$210
Oct 30, 2026Casey WoodringJ.P. MorganBuyMaintained$300
Oct 30, 2026Vijay KumarEvercore ISIBuyMaintained$275
Consensus over the last 12 months buy hold sell avg. target month-end close
Monthly buy, hold and sell shares of analyst ratings with the average price target and the month-end close$120$140$160$180$200$220$240$260$280Dec 25 · Buy 7 · Hold 10 · Sell 3Dec 25Jan 26 · Buy 6 · Hold 9 · Sell 3Feb 26 · Buy 5 · Hold 6 · Sell 3Feb 26Mar 26 · Buy 4 · Hold 6 · Sell 3Apr 26 · Buy 4 · Hold 6 · Sell 3Apr 26May 26 · Buy 6 · Hold 5 · Sell 3Jun 26 · Buy 7 · Hold 4 · Sell 3Jun 26Jul 26 · Buy 8 · Hold 5 · Sell 3Aug 26 · Buy 8 · Hold 5 · Sell 3Aug 26Sep 26 · Buy 11 · Hold 5 · Sell 3Oct 26 · Buy 11 · Hold 7 · Sell 4Oct 26Nov 26 · Buy 11 · Hold 7 · Sell 4Dec 25 · avg. target $118Jan 26 · avg. target $124Feb 26 · avg. target $129Mar 26 · avg. target $128Apr 26 · avg. target $130May 26 · avg. target $140Jun 26 · avg. target $152Jul 26 · avg. target $186Aug 26 · avg. target $192Sep 26 · avg. target $211Oct 26 · avg. target $244Nov 26 · avg. target $244Dec 25 · month-end close $131Jan 26 · month-end close $145Feb 26 · month-end close $134Mar 26 · month-end close $123Apr 26 · month-end close $127May 26 · month-end close $163Jun 26 · month-end close $176Jul 26 · month-end close $205Aug 26 · month-end close $214Sep 26 · month-end close $274Oct 26 · month-end close $236Nov 26 · month-end close $236

Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.

TipRanks data · computed Nov 5, 2026 · 113 ratings

Frequently asked questions

Where can I trade ILMN perpetual futures?

Illumina, Inc. (ILMN) perpetual futures trade on 1 crypto venues, including MEXC. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade ILMN around the clock?

Yes. Unlike the underlying stock, ILMN perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on ILMN perpetuals?

Right now the ILMN perp funding rate is +21.9% annualized (venue median), ranging from +21.9% to +21.9% across 1 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the ILMN perp price compare to the Illumina, Inc. stock?

The venue-median ILMN perp mark is $207.6 versus a reference stock price of $207.6, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a ILMN perpetual future?

A ILMN perpetual is a derivative that tracks the price of Illumina, Inc. with no expiry date. It lets you take long or short exposure to Illumina, Inc. on crypto venues, around the clock.

What is ILMNUSDT perpetual?

ILMNUSDT is the symbol most crypto exchanges use for the Illumina, Inc. perpetual settled in USDT (Tether). It tracks the ILMN share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

ILMN perpetuals · perpequities.comILMN perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/ilmn-perp"><img src="https://perpequities.com/badge/ilmn-perp.svg" width="240" height="64" alt="ILMN perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of ILMN perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for ILMN — one email every Sunday.

Watchlist and alerts

Price and funding alerts for ILMN, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X